The FDA Called. They’d Like to See Everything

FDA inspections don’t arrive with much ceremony. There’s no buildup—just a badge, a few introductions, and then a steady stream of questions about your documents, your systems, and your people.

What has changed is everything around that moment. Inspections are happening more often, follow-ups are quicker, and tolerance for “we’ll fix it later” has narrowed considerably.

If the working assumption is “we’ll deal with it when it happens,” that’s usually when problems start to compound.

 

Why Inspections Matter More Now

Inspections are no longer procedural checkpoints. They are increasingly used to evaluate how a company actually operates in real time.

Regulators are:

• Targeting based on risk signals—including complaints, digital presence, and supply chain patterns
• Using hybrid approaches, reviewing records remotely before stepping on-site
• Focusing closely on data integrity, where inconsistencies tend to unravel broader issues

The result is a more complete picture of a business—one that goes beyond written procedures and into execution.

 

How Issues Typically Build

Enforcement actions rarely trace back to a single failure. More often, they reflect a pattern of smaller gaps that were never fully addressed:

• SOPs that don’t reflect current practices
• CAPAs that stall before resolution
• Training records that check a box but don’t demonstrate understanding
• Documentation that raises follow-up questions instead of closing them
• Employees who aren’t sure how to respond when asked to walk through a process

Individually, these are manageable. Together, they tell a different story.

 

What Preparation Actually Looks Like

Effective preparation tends to be less about intensity and more about consistency.

 

Start before it matters.

Routine internal or mock audits—whether desktop or on-site—help surface issues early, when they are easier to correct.

 

Interrogate your own data.

Look at records the way an investigator would:

• Does this deviation make sense on its own?
• Do our documents match what actually happens?
• Would someone unfamiliar with our process find this credible?

If the answers aren’t clear, it’s worth tightening.

 

Train for real interactions.
Inspections hinge on how people respond in the moment. Preparation should include practicing how to locate records, explain processes, and handle questions—not just signing off on training modules.

 

Treat inspections as part of operations.
Companies that navigate inspections well tend to approach them as structured conversations, not emergencies. Organization and consistency go further than defensiveness.

 

A Familiar Pattern

Investigators tend to notice the same things over and over:

• Recently updated procedures that don’t match prior records
• Open-ended commitments without resolution
• Environments that feel staged rather than lived-in

What stands out, instead, is clarity—when records align, explanations are straightforward, and the system reflects how work actually gets done.

 

The Takeaway

Inspections don’t tend to reward last-minute effort. They reflect what was already in place.

Preparation, in this context, isn’t about anticipating every question. It’s about making sure the answers are already there—in the data, in the systems, and in the people responsible for them.

 

A Practical Next Step

If it’s been a while since your last internal review, or if your last audit didn’t fully simulate an inspection environment, it may be worth taking a fresh look—ideally with someone who hasn’t been close to the day-to-day.

Not as a fire drill, but as a way to see what others will see when it counts.

For assistance with FDA inspection preparation including audits and 483 responses, please email info@garg-law.com.